Ferraris First Electric Vehicle Faces Market Skepticism as Luxury Brand Ventures into EV Territory Amazon and GE Vernova Highlight Market Momentum as Stocks Approach Key Levels Bond Market Signals Fed May Be Behind Curve on Inflation as Warsh Assumes Leadership Swiss Franc and Japanese Yen Strengthen as DeepSeeks AI Model Sparks SafeHaven Demand Lenovo Posts StrongerThanExpected Q4 Revenue Amid Robust PC Demand Shares Climb Vietnam Nears Signing of BrahMos Cruise Missile Deal with India Boosting Defense Ties RBA Q1 2026 Earnings EPS Surpasses Expectations Stock Gains Modestly FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business CISO Global Q2 2025 Earnings Narrowed Loss Drives 2787 Stock Surge LUXE Q1 2026 Earnings EPS Miss Weighs on Sentiment as Revenue Data Remains Withheld NE Q1 2026 Earnings EPS Beats by 301 on Robust Operational Performance TD SYNNEX SNX Q1 2026 Earnings Strong EPS Beat of 416 Overshadowed by Tepid Stock Response Blackrock MuniYield Quality Fund MQY Inches Higher Amid Steady Municipal Bond Market Northann Corp NCL Faces Continued Pressure Near Support Levels ProMIS Neurosciences PMN Slips 565 as Shares Test Key Support Level TopBuild Corp BLD Shares Edge Lower Amid Consolidation Key Levels in Focus Cloudastructure CSAI Rallies Slightly Approaches Key Resistance at 050 General Motors Expands Luxury EV Lineup with Cadillac Vistiq Targeting 300Mile Range AFYA Q1 2026 Earnings EPS Misses Estimates Stock Gains 218 TOMI Environmental Solutions TOMZ Edges Higher as Stock Tests Key Resistance at 093 SWMR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Surges 139 BOOM Q1 2026 Earnings EPS Surprises to the Upside Despite Loss JFIN Q4 2024 Earnings Strong EPS Performance Drives Stock Rally John Wiley Sons Inc WLYB Q1 2026 Earnings EPS Surpasses Estimates Stock Unchanged ENIC Q4 2025 Earnings EPS Beat Exceeds Expectations Amid Mixed Revenue Disclosures Woodward Inc WWD Q1 2026 Earnings EPS Surges Past Estimates Stock Declines SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development